Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT-Reference-Cited by-同舟云学术

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT

Published:2017-06 Issue: Volume:89 Page:97-104
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Kato Masaki,Takekita Yoshiteru,Koshikawa Yosuke^ORCID,Sakai Shiho,Bandou Hiroki,Nishida Keiichiro,Sunada Naotaka^ORCID,Onohara Ai,Hatashita Yoshiyuki,Serretti Alessandro,Kinoshita Toshihiko

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference20 articles.

1. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatric Association,1994

2. A review of the pharmacological and clinical profile of mirtazapine;Anttila;CNS Drug Rev.,2001

3. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders;Bauer;World J. Biol. Psychiatry,2013

4. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation;Blier;Eur. Neuropsychopharmacol.,2009

5. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study;Blier;Am. J. Psychiatry,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs as potential biomarkers for diagnosis of major depressive disorder and influence of antidepressant treatment;NeuroMarkers;2024-09

2. Relationship between circulating mitochondrial DNA and microRNA in patients with major depression;Journal of Affective Disorders;2023-10

3. Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study;European Journal of Clinical Pharmacology;2023-09-13

4. Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis;International Journal of Molecular Sciences;2023-07-30

5. Rethinking the medication management of major depression;Expert Review of Neurotherapeutics;2023-04-03